- Home
- LUCD vs TSAT Comparison
LUCD vs TSAT Comparison
Compare LUCD & TSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- TSAT
- Stock Information
- Founded
- LUCD 2018
- TSAT 1969
- Country
- LUCD United States
- TSAT Canada
- Employees
- LUCD 70
- TSAT N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- TSAT Metal Fabrications
- Sector
- LUCD Health Care
- TSAT Industrials
- Exchange
- LUCD Nasdaq
- TSAT Nasdaq
- Market Cap
- LUCD 135.6M
- TSAT N/A
- IPO Year
- LUCD 2021
- TSAT 1996
- Fundamental
- Price
- LUCD $1.15
- TSAT $17.03
- Analyst Decision
- LUCD Strong Buy
- TSAT
- Analyst Count
- LUCD 4
- TSAT 0
- Target Price
- LUCD $3.88
- TSAT N/A
- AVG Volume (30 Days)
- LUCD 1.3M
- TSAT 79.1K
- Earning Date
- LUCD 05-14-2025
- TSAT 05-06-2025
- Dividend Yield
- LUCD N/A
- TSAT N/A
- EPS Growth
- LUCD N/A
- TSAT N/A
- EPS
- LUCD N/A
- TSAT N/A
- Revenue
- LUCD $4,346,000.00
- TSAT $372,642,710.00
- Revenue This Year
- LUCD $107.75
- TSAT N/A
- Revenue Next Year
- LUCD $231.37
- TSAT N/A
- P/E Ratio
- LUCD N/A
- TSAT N/A
- Revenue Growth
- LUCD 79.00
- TSAT N/A
- 52 Week Low
- LUCD $0.63
- TSAT $7.18
- 52 Week High
- LUCD $1.80
- TSAT $25.38
- Technical
- Relative Strength Index (RSI)
- LUCD 41.93
- TSAT 46.61
- Support Level
- LUCD $1.19
- TSAT $14.77
- Resistance Level
- LUCD $1.24
- TSAT $17.32
- Average True Range (ATR)
- LUCD 0.07
- TSAT 1.03
- MACD
- LUCD -0.00
- TSAT 0.12
- Stochastic Oscillator
- LUCD 15.79
- TSAT 50.34
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.